The introduction of the Retatrutide vial signifies a significant shift in the landscape to metabolic regulation. This groundbreaking therapy combines dual mechanisms – stimulation of the GLP-1 target and blocking of the DPP-4 factor – providing a different strategy for managing obesity . Early patie